Form 4: Aveanna CEO Sells Shares for Tax Obligations

Aveanna Healthcare Holdings CEO Jeff Shaner sold 84,960 shares of common stock over three days in late 2025 and early 2026 to cover tax obligations from vested equity awards.

Summary

• Jeff Shaner, Chief Executive Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported the sale of 84,960 shares of common stock across three separate transactions.
• The sales occurred on December 30, 2025 (27,929 shares), December 31, 2025 (27,674 shares), and January 2, 2026 (29,357 shares).
• The weighted average sale prices were $8.3556, $8.1777, and $7.8452 per share, respectively, totaling approximately $699,992.5.
• These transactions were executed pursuant to a Rule 10b5-1(c) plan, indicating they were pre-arranged.
• The shares were automatically sold to satisfy tax obligations incurred from the vesting of equity awards.
• Following these transactions, Jeff Shaner beneficially owns 2,394,179 shares of Aveanna Healthcare Holdings common stock.
• The reported beneficial ownership includes 1,500 shares acquired under the Registrant's Employee Stock Purchase Plan (ESPP) in July 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it represents a reduction in direct ownership, the sales are for tax obligations related to vested equity awards and were pre-planned under Rule 10b5-1, which is a routine event for executives and does not typically signal a lack of confidence in the company's future.

Positives

• The sales were explicitly for tax obligations related to vested equity awards, which is a common and often pre-planned event for executives, rather than a discretionary sale signaling a lack of confidence.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled and not based on new, non-public information.
• Jeff Shaner retains a significant beneficial ownership of 2,394,179 shares after these sales, demonstrating continued alignment with shareholder interests.
• The CEO previously acquired 1,500 shares through the Employee Stock Purchase Plan in July 2025, indicating some prior accumulation of shares.

Negatives

• The transactions represent a reduction in the CEO's direct beneficial ownership of the company's common stock by 84,960 shares.
• The weighted average sale price for the shares declined over the three transaction days, from $8.3556 on December 30, 2025, to $7.8452 on January 2, 2026.

Risks

• N/A. This Form 4 filing is a transactional report and does not detail specific company risks.

Future Outlook

N/A. This filing is a transactional report of insider stock sales and does not provide forward-looking statements or guidance.

Management Comments

• N/A. This Form 4 reports a transaction and does not include direct management comments or quotes.

Industry Context

N/A. This Form 4 details an insider transaction and does not provide broader industry context or analysis.

Comparison to Industry Standards

• N/A. This filing reports an insider transaction and does not contain information for comparison to industry standards or competitor activities.

Management Changes

Corporate Governance

Legal Proceedings

• N/A. This filing does not report any litigation or regulatory matters.

Related Party Transactions

• The reported sales of common stock by Jeff Shaner, the Chief Executive Officer, constitute related party transactions as they involve an executive of the company.

Stakeholder Impact

• Shareholders: A reduction in direct ownership by the CEO, even for tax purposes, might be viewed neutrally to slightly negatively by some investors. However, the pre-planned nature under Rule 10b5-1(c) and the reason (tax obligations) mitigate concerns about management's confidence in the company's future prospects.
• Employees: No direct impact is indicated by this transactional filing.

Next Steps

• N/A. This filing reports past transactions and does not outline future actions, events, or milestones for the company or the reporting person.

Key Dates

Recommendation

The sales by CEO Jeff Shaner are explicitly stated to be for tax obligations arising from vested equity awards and were conducted under a Rule 10b5-1 plan. This indicates a non-discretionary, pre-scheduled transaction rather than a signal of lack of confidence in the company's future. While it reduces the CEO's direct holdings, the underlying reason is routine for executive compensation. Therefore, this specific Form 4 filing alone does not warrant a change from a 'hold' position, as it doesn't introduce new fundamental information about the company's operational performance or strategic direction.

Keywords

Aveanna Healthcare Holdings, AVAH, Jeff Shaner, Insider Sale, Form 4, Equity Awards, Tax Obligation, CEO, Stock Sale, Rule 10b5-1